Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Collection
For ¥0.57 per day, unlimited downloads CREATE MEMBERSHIP Download

toTop

If you have any feedback, Please follow the official account to submit feedback.

Turn on your phone and scan

home > search >

Management and prognosis of pure primary squamous cell carcinoma of the breast

Author:
Benoist, P.  Mureau, A.  Joueidi, Y.  Arbion, F.  Vilde, A.  Body, G.  Michenet, P.  Leveque, J.  Ouldamer, L.  


Journal:
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION


Issue Date:
2018


Abstract(summary):

Purpose. - The aim of the study was to investigate the management and prognosis of Pure primary squamous cell carcinoma (PPSCC) of the breast. Materials and methods. - This study is a multicentre retrospective cohort from three French tertiary referral hospitals (Rennes, Orleans and Tours) including all women treated for a PPSCC of the breast defined by squamous cells that could contain a minority of sarcomatoid component. We excluded carcinomas with a ductual component. Clinicopathologic, radiological and therapeutic patterns were described. Demographic, histological and therapeutic characteristics were compared to a population of women with triple negative invasive breast carcinomas. Results. - Twelve patients were included, with a mean age of 71.6 years. All lesions were unifocal, with a cystic complex ultrasound mass in 50% of cases. Mean tumor size was 43 mm, with axillary lymph node metastasis in 25% of patients. The comparison with a population of women with triple negative breast carcinomas revealed that women with PPSCC were older (71 versus 57 years, p =3D 0.003), tumor size was larger (43 mm versus 25 mm, p =3D 0.032) and local recurrence occurred earlier (three months versus 38 months, p =3D 0.014). Conclusion. - PPSCC is a rare entity with a worse prognosis in comparison with triple negative invasive carcinoma. (C) 2018 Published by Elsevier Masson SAS.


Page:
275---280


VIEW PDF

The preview is over

If you wish to continue, please create your membership or download this.

Create Membership

Similar Literature

Submit Feedback

This function is a member function, members do not limit the number of downloads